Mistry S, Sudharshan S, Ganesan S, Akbar AB, Biswas J. Vogt-Koyanagi-Harada disease like presentation in patients with chronic myeloid leukemia.
Am J Ophthalmol Case Rep 2018;
10:221-225. [PMID:
29780937 PMCID:
PMC5956718 DOI:
10.1016/j.ajoc.2018.03.010]
[Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Revised: 02/08/2018] [Accepted: 03/08/2018] [Indexed: 12/20/2022] Open
Abstract
Purpose
To report two rare cases of chronic myeloid leukemia (CML) on tyrosine kinase inhibitors presenting as bilateral serous retinal detachment and ocular inflammation, simulating Vogt-Koyanagi-Harada (VKH) disease.
Methods
Case series and review of literature.
Result
Two young patients (one male and one female) with CML on treatment with tyrosine kinase inhibitors (imatinib and dasatanib) under remission presented with bilateral sudden vision loss. One patient had bilateral multiple pockets of serous retinal fluid while the other had panuveitis with exudative retinal detachment. There was neither prodromal symptoms nor systemic signs and symptoms suggestive of VKH in both cases. They responded well to systemic steroid therapy without recurrences with complete visual recovery.
Conclusion and importance
CML patients can have features similar to VKH even during stable hematological phase and may be possibly associated with the use of tyrosine kinase inhibitors. Hence it is important not to misdiagnose and treat such patients with long term immunomodulators.
Collapse